
Frontera Health, a Denver, CO-based AI-enabled autism care company, has raised $32 million in seed funding.
Investors
The round was co-led by Lux Capital and Lightspeed Venture Partners, with Bison Ventures, Menlo Ventures, and Inspired Capital participating.
Lux Capital is a venture capital firm that invests in innovative, high-growth companies across various sectors, including healthcare, technology, and energy. The firm focuses on funding disruptive technologies and visionary entrepreneurs who are shaping the future in industries such as AI, robotics, and life sciences.
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations in the enterprise, consumer, fintech, and health sectors. With $25B in AUM, it has backed over 500 companies globally over two decades, with teams across the U.S., Europe, India, Israel, and Southeast Asia.
Frontera Health Use of Funds
The company will use the funds to scale its AI-powered clinical solutions.
About Frontera Health
Frontera Health is a technology company that offers AI-powered solutions to help clinicians improve access to care for individuals with autism and related disorders in more communities, particularly rural and underserved areas. Its AI-powered Frontera Digital Phenotyping solution, designed to analyze therapeutic sessions in great detail, helps clinicians enhance data-driven care and expand access to early intervention. Additionally, Frontera develops AI tools to streamline administrative tasks, such as the diagnosis builder and assessment builder.
Funding Details
Company: Frontera Health, Inc.
Raised: $32.0M
Round: Seed Round
Funding Date: February 2025
Lead Investors: Lux Capital, Lightspeed Venture Partners
Additional Investors: Bison Ventures, Menlo Ventures, Inspired Capital
Company Website: https://fronterahealth.com/
Software Category: AI Healthcare Solutions
Source: https://www.businesswire.com/news/home/20250218656544/en